| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 06/10/2023 | 22h07 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 28/09/2023 | 22h30 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 27/09/2023 | 01h18 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 23h25 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h25 | Edgar (US Regulatory) | Form POSASR - Post-effective Amendment to an automatic shelf registration statement | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h23 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h22 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h21 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h20 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h19 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h18 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h17 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h16 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h15 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 22h14 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 26/09/2023 | 14h59 | GlobeNewswire Inc. | Biogen Completes Acquisition of Reata Pharmaceuticals | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 21/09/2023 | 22h05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 21/09/2023 | 16h08 | Business Wire | Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc. | NASDAQ:RETA | Reata Pharmaceuticals Inc |